PAVmed Inc (PAVM) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
PAVmed Inc stock (PAVM) is currently trading at $9.30. PAVmed Inc PS ratio (Price-to-Sales) is 312.28. Analyst consensus price target for PAVM is $510.00. WallStSmart rates PAVM as Sell.
- PAVM PE ratio analysis and historical PE chart
- PAVM PS ratio (Price-to-Sales) history and trend
- PAVM intrinsic value — DCF, Graham Number, EPV models
- PAVM stock price prediction 2025 2026 2027 2028 2029 2030
- PAVM fair value vs current price
- PAVM insider transactions and insider buying
- Is PAVM undervalued or overvalued?
- PAVmed Inc financial analysis — revenue, earnings, cash flow
- PAVM Piotroski F-Score and Altman Z-Score
- PAVM analyst price target and Smart Rating
PAVmed Inc
📊 No data available
Try selecting a different time range
Smart Analysis
PAVmed Inc (PAVM) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, profit margin. Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
PAVmed Inc (PAVM) Key Strengths (3)
Keeps $10672 of every $100 in revenue as net profit
Trading at 1.07x book value, attractively priced
Solid profitability: $17 profit per $100 equity
Supporting Valuation Data
PAVmed Inc (PAVM) Areas to Watch (5)
Losing money on operations
Revenue declining -99.50%, a shrinking business
Very expensive at 312.3x annual revenue
Very low institutional interest at 7.04%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
PAVmed Inc (PAVM) Detailed Analysis Report
Overall Assessment
This company scores 33/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 3 register as strengths (avg 8.3/10) while 5 fall into concern territory (avg 1.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Profit Margin, Price/Book, Return on Equity. Valuation metrics including Price/Book (1.07) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 17.40%, Profit Margin at 10672.00%.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, Price/Sales. Some valuation metrics including Price/Sales (312.28) suggest expensive pricing. Growth concerns include Revenue Growth at -99.50%, which may limit upside. Profitability pressure is visible in Operating Margin at -96880.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 17.40% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at -99.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PAVM Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PAVM's Price-to-Sales ratio of 312.28x trades 680% above its historical average of 40.04x (90th percentile), historically expensive. The current valuation is 8% below its historical high of 341.19x set in Mar 2026, and 346878% above its historical low of 0.09x in Dec 2025. Over the past 12 months, the PS ratio has expanded from ~0.2x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for PAVmed Inc (PAVM) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
PAVmed Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 29,000 with 100% decline year-over-year. Profit margins are strong at 10672.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 1740.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Debt-to-equity ratio of 0.26 indicates a conservative balance sheet with 3M in cash.
Revenue contracted 100% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -899,000, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact PAVmed Inc.
Bottom Line
PAVmed Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About PAVmed Inc(PAVM)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.